CE: Emerging Strategies in the Treatment and Management of Idiopathic Pulmonary Fibrosis

Pharmacy Times, April 2020, Volume 88, Issue 4

This activity is supported by an educational grant from Genentech.

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

  • Explore the pathophysiology and treatment challenges associated with idiopathic pulmonary fibrosis (IPF)
  • Examine the safety and efficacy of available therapies for the treatment of IPF
  • Identify the role of the specialty pharmacist as patient counselor in the management of IPF

FACULTY

Geoffrey C. Wall, PharmD, BCPS, FCCP

Ellis Professor of Pharmacy Practice, Drake University College of Pharmacy and Health Sciences; Internal Medicine Clinical Pharmacist, Iowa Methodist Medical Center, Des Moines, Iowa

TARGET AUDIENCE: Pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: April 13, 2020

EXPIRATION DATE: April 13, 2021

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.